Overview

The Drug-Drug Interaction of SHR4640 and Febuxostat in Patients With Hyperuricemia

Status:
Unknown status
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the pharmacodynamic properties of drug-drug of SHR4640 and Febuxostat interaction in patients with Hyperuricemia.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Febuxostat